Related Experiment Video
Updated: Aug 25, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
AMBRA1 and its role as a target for anticancer therapy
Xiang Li1,2, Yuan Lyu2,3, Junqi Li2,3
1Department of Neurosurgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China.
Activating molecule in Beclin1-regulated autophagy protein 1 (AMBRA1) influences cancer cell survival and death by modulating autophagy. Targeting AMBRA1 presents a potential therapeutic strategy for cancer treatment.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- The activating molecule in Beclin1-regulated autophagy protein 1 (AMBRA1) is intrinsically disordered.
- AMBRA1 regulates cancer cell survival and death via autophagy modulation.
- Autophagy's role in cancer is complex and context-dependent, yet its inhibition can be therapeutic.
Purpose of the Study:
- To review the mechanisms of AMBRA1 in autophagy, mitophagy, and apoptosis.
- To highlight AMBRA1's roles in tumorigenesis and targeted cancer therapy.
Main Methods:
- Literature review focusing on AMBRA1's molecular functions.
- Analysis of AMBRA1's involvement in cancer cell proliferation and cell cycle regulation.
- Synthesis of evidence regarding AMBRA1's impact on cancer progression.
Main Results:
- AMBRA1 is a key regulator of autophagy, mitophagy, and apoptosis.
- AMBRA1 also inhibits cancer development by controlling c-MYC and cyclin pathways.
- AMBRA1 acts at the intersection of autophagy, cell proliferation, and the cell cycle.
Conclusions:
- AMBRA1 is a crucial protein linking autophagy and cancer.
- Targeting AMBRA1 offers a promising avenue for novel cancer therapies.
- Understanding AMBRA1's multifaceted roles is essential for developing effective cancer treatments.
More Related Videos
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Drugs that Destabilize Microtubules